Financials
Financial year 2025
Worth noting
- Figures corrected afterwards (2022).
Revenue
€ 351.2 million
▲ 11% vs 2024
Profit
Growing€ 8.6 million
▲ 6% vs 2024
Debts
Low€ 58.5 million
▲ 17% vs 2024
AstraZeneca from Dilbeek, company number BE0400165679, closed financial year 2025 with a result of € 8.6 million after tax. For that financial year AstraZeneca recorded revenue of € 351.2 million and equity of € 46.9 million. Compared with financial year 2024, the result moved from € 8.2 million to € 8.6 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 17, 2026.
What happened at AstraZeneca?
What happened at AstraZeneca in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Luca Taliercio stepped down as director. NBB
- Paul Van Mullem stepped down as director. NBB
- Jennifer Olivero stepped down as director. NBB
- Angela Thompson stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 8.6 million (▲ 6% vs 2024). Source: NBB ↗
- New establishment in Mont-Saint-Guibert. KBO
- New establishment in Mont-Saint-Guibert. KBO
- Angela Thompson became a director. NBB
In short
From € 3.9 million profit in 2021 to € 8.6 million profit in 2025.
Paid € 13.6 million in corporate taxes since 2021.
Best year ever: 2023, with € 9.1 million profit.
Paid out € 33 million in dividends to the owners in total.
A new publication or filing at AstraZeneca? We notify you, reason included.
Follow AstraZenecaNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by AstraZeneca Continent BV and AstraZeneca Gamma BV.
Directors
According to the 2025 annual accounts
Luca Taliercio
Director
since 2022 · until 2028
Paul Van Mullem
Director
since 2022 · until 2028
Jennifer Olivero
Director
since 2022 · until 2028
Angela Thompson
Managing director
since 2025 · until 2028
Shareholders
AstraZeneca Continent BV
AstraZeneca Gamma BV
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Alfons Gossetlaan 40 box 201
1702 Dilbeek
Rue André Dumont 5
1435 Mont-Saint-Guibert
Active since 1 October 2025
Rue André Dumont 9
1435 Mont-Saint-Guibert
Active since 1 October 2025
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 14 companies are registered at this address.
Intersong-Primavera, Editions Musicales
€ 42,007 revenue · 2024
Babel Music
€ 3,662 revenue · 2024
WARNER MUSIC BENELUX
€ 4.5 million gross margin · 2025
Amplifon Belgium
€ 47.6 million revenue · 2025
WARNER CHAPPELL MUSIC BELGIUM
€ 4 million revenue · 2024
+9 more
Details
- Company number
- 0400.165.679
- VAT number
- BE 0400.165.679
- Registered office
- Alfons Gossetlaan 40 bus 201, 1702 Dilbeek
- Names & denominations
- AstraZeneca
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 28 November 1948
- Peppol
- Active · Active since 30 Dec 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten